Global Health Limited (Medanta) has made a regulatory disclosure pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding the allotment of equity shares under its employee stock option plan.

Key Quantitative Figures

  • Number of shares allotted: 15,900 Equity Shares
  • Face value per share: Rs. 2/- each
  • Issue premium per share: Rs. 1,239
  • Total issue price per share: Rs. 1,241
  • Pre-allotment paid-up share capital: Rs. 53,77,03,764/- divided into 26,88,51,882 Equity Shares
  • Post-allotment paid-up share capital: Rs. 53,77,35,564/- divided into 26,88,67,782 Equity Shares
  • Distinctive share numbers: 26,88,51,883 to 26,88,67,782 (both inclusive)

Dates of Action

  • Allotment date: May 23, 2026
  • Committee resolution date: May 23, 2026 (passed by circulation)
  • Previous regulatory filings: ESOP filed on March 19, 2025 (BSE Case No. 227579, NSE Case No. 47722) and ESPS filed on April 08, 2025 (BSE Case No. 229491, NSE Case No. 48081)

Parties Involved

  • Issuing company: Global Health Limited
  • Allottee: GHL Employees Welfare Trust (ESOP Trust)
  • Approving authority: Nomination & Remuneration Committee (NRC)
  • Regulatory references: SEBI Listing Regulations, Regulation 30; SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021, Regulation 10(c)
  • Stock exchanges: BSE Limited, National Stock Exchange of India Limited

Purpose and Rationale

The shares were allotted to the ESOP Trust under the GHL LTIP 2024 Plan and will be transferred to eligible employees' Demat accounts as per the provisions of the Scheme.

Capital Structure Impact

The allotment resulted in an increase of 15,900 equity shares, changing the total number of shares from 26,88,51,882 to 26,88,67,782. The new shares will rank pari-passu with existing equity shares in all respects.

Financial Impact

The shares were issued to the ESOP Trust at Rs. 1,241 per share (Rs. 2 face value + Rs. 1,239 premium). Employees will exercise options at Rs. 2 per equity share. The transaction represents a capital infusion of approximately Rs. 19.73 lakh (15,900 shares × Rs. 1,241) to the company.

Additional Details

  • No lock-in restrictions apply to the allotted shares
  • No share certificate numbers applicable (Demat form)
  • No listing fees payable
  • The disclosure includes Annexure-A and Annexure-B with required regulatory details